Daniel Ackermann
University of St. Gallen
9 Papers
14 Citations
Daniel Ackermann is an academic researcher from University of St. Gallen. The author has contributed to research in topics: Transitional cell carcinoma & Tissue microarray. The author has an hindex of 8, co-authored 9 publications. Previous affiliations of Daniel Ackermann include Kantonsspital St. Gallen.
Chat about Author
Papers
High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer
Jan Richter,Urs Wagner,Juha Kononen,André Fijan,James Bruderer,Ulrico Schmid,Daniel Ackermann,Robert Maurer,Göran Alund,Hartmut Knönagel,Marcus Rist,Kim Wilber,Manuel Anabitarte,Franz Hering,Thomas Hardmeier,Andreas Schönenberger,Renata Flury,Peter Jäger,Jean Luc Fehr,Peter Schraml,Holger Moch,Michael J. Mihatsch,Thomas C. Gasser,Olli Kallioniemi,Guido Sauter +24 more
TL;DR: This analysis of the prognostic impact of CCNE gene amplification and protein expression in >1,500 arrayed bladder cancers was accomplished in a period of 2 weeks, illustrating how the tissue microarray technology remarkably facilitates the evaluation of the clinical relevance of molecular alterations in cancer.
270
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men,Edith Uetz-von Allmen,Markus Fopp,Roger von Moos,Christel Böhme,Hans-Peter Schmid,Daniel Ackermann,Thomas Cerny,Burkhard Ludewig,Marcus Groettrup,Silke Gillessen +10 more
TL;DR: DC-based multi-epitope immunotherapy with repeated boosting in men with hormone-refractory prostate carcinoma is feasible and generates efficient cellular antitumor responses.
Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study.
Thomas Kocher,Thomas Kocher,Min Zheng,Martin Bolli,Ronald Simon,Thomas Forster,Elke Schultz-Thater,Eugenia Remmel,Christoph Noppen,U. Schmid,Daniel Ackermann,Michael J. Mihatsch,Thomas Gasser,Michael Heberer,Guido Sauter,Giulio C. Spagnoli +15 more
TL;DR: Evaluation of MAGE‐A4 protein expression is useful in the identification of groups of TCCs characterized by severe prognosis, thus possibly providing indications for early MAGE TAA‐targeted immunotherapy.
78
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
Urs Wagner,Katrin Süess,Thomas Luginbühl,Ulrico Schmid,Daniel Ackermann,Tobias Zellweger,Robert Maurer,Göran Alund,Hartmut Knönagel,Marcus Rist,Paul Jordan,Holger Moch,Michael J. Mihatsch,Thomas C. Gasser,Guido Sauter +14 more
TL;DR: It is concluded that cyclin D1 positivity distinguishes a large subgroup of papillary bladder tumours, but there is no evidence of prognostic significance for increased cyclinD1 expression.
51
Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma
Valeriu Toma,Dieter Hauri,Ulrico Schmid,Daniel Ackermann,Robert Maurer,Göran Alund,Hartmut Knönagel,Marcus Rist,Thomas C. Gasser,Guido Sauter,Jürgen Roth +10 more
TL;DR: The results indicate the value of conventional CD44 immunohistochemistry as an additional tool for identifying patients at high risk for recurrence of pTa transitional cell carcinomas of the bladder and point to biological differences between noninvasive and minimally invasive transitional cell cancers.
41